{"ticker": "TROV", "overview": {"cik": "1213037", "ticker": "CRDF", "name": "Cardiff Oncology, Inc.", "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "sic": "2836", "announcements": [{"form": "3", "date": "2026-10-27", "title": "Initial insider holdings", "accession": "0001493152-26-048722", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-27", "title": "Material event", "accession": "0001493152-26-048720", "price_sensitive": true}, {"form": "8-K", "date": "2026-10-22", "title": "Material event", "accession": "0001493152-26-048111", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "Material event", "accession": "0001493152-26-042506", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-08-26", "title": "Form DEFA14A", "accession": "0001193125-26-368287", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-08-26", "title": "Proxy statement", "accession": "0001193125-26-368249", "price_sensitive": false}, {"form": "PRE 14A", "date": "2026-08-14", "title": "Form PRE 14A", "accession": "0001193125-26-352135", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001193125-26-344645", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001193125-26-344545", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-07-27", "title": "Form SCHEDULE 13G/A", "accession": "0002012383-26-002222", "price_sensitive": false}, {"form": "S-8", "date": "2026-07-21", "title": "Employee share plan", "accession": "0001193125-26-310273", "price_sensitive": false}, {"form": "4", "date": "2026-07-16", "title": "Insider transaction", "accession": "0001193125-26-306083", "price_sensitive": false}, {"form": "4", "date": "2026-07-16", "title": "Insider transaction", "accession": "0001193125-26-306072", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-16", "title": "Material event", "accession": "0001193125-26-305467", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-16", "title": "Prospectus", "accession": "0001193125-26-305465", "price_sensitive": false}, {"form": "4", "date": "2026-06-22", "title": "Insider transaction", "accession": "0001664708-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-22", "title": "Insider transaction", "accession": "0001184778-26-000009", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001370087-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001635493-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001543174-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001393415-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001184778-26-000007", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-11", "title": "Material event", "accession": "0001193125-26-267563", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-03", "title": "Material event", "accession": "0001193125-26-254658", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-29", "title": "Material event", "accession": "0001193125-26-248711", "price_sensitive": true}]}, "description": "TROV trades as TROV. Privy Trades holds 149 insider filings for the company, from April 2012 to June 2018. Across those, 11 insiders disclosed 25 open-market purchases totalling $7.68M against 2 sales totalling $162.94K. The most recent filing on record is dated 16 April 2020.", "exchange": null, "stats": {"buy_n": 25, "buy_sum": 7678150.67, "sell_n": 2, "sell_sum": 162938.46, "net": 7515212.21, "insiders": 11, "first_date": "2012-04-13", "last_date": "2018-06-20"}, "metrics": {"ticker": "TROV", "has_prices": false}, "trades": [{"id": "0001104659-20-055489", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Lale White", "who_key": "White Lale", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465920055489/0001104659-20-055489-index.htm", "trade_date": "2020-04-16", "timestamp": "2020-04-16", "mins": 3444049}, {"id": "0001104659-20-055491", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "James O. Armitage", "who_key": "Armitage James O", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465920055491/0001104659-20-055491-index.htm", "trade_date": "2020-04-16", "timestamp": "2020-04-16", "mins": 3444049}, {"id": "0001104659-20-055492", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Gary W. Pace", "who_key": "PACE GARY W", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465920055492/0001104659-20-055492-index.htm", "trade_date": "2020-04-16", "timestamp": "2020-04-16", "mins": 3444049}, {"id": "0001104659-20-000872", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465920000872/0001104659-20-000872-index.htm", "trade_date": "2020-01-03", "timestamp": "2020-01-03", "mins": 3593809}, {"id": "0001104659-20-000881", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465920000881/0001104659-20-000881-index.htm", "trade_date": "2020-01-03", "timestamp": "2020-01-03", "mins": 3593809}, {"id": "0001104659-19-052973", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465919052973/0001104659-19-052973-index.htm", "trade_date": "2019-10-01", "timestamp": "2019-10-01", "mins": 3729169}, {"id": "0000899243-19-019005", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319019005/0000899243-19-019005-index.htm", "trade_date": "2019-07-01", "timestamp": "2019-07-01", "mins": 3861649}, {"id": "0000899243-19-017915", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "John P. Brancaccio", "who_key": "BRANCACCIO JOHN P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017915/0000899243-19-017915-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-017916", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Athena Countouriotis", "who_key": "Countouriotis Athena", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017916/0000899243-19-017916-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-017920", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017920/0000899243-19-017920-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-017921", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017921/0000899243-19-017921-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-017922", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Thomas Adams PhD", "who_key": "ADAMS THOMAS PHD", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017922/0000899243-19-017922-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-017923", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Gary S. Jacob", "who_key": "JACOB GARY S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319017923/0000899243-19-017923-index.htm", "trade_date": "2019-06-20", "timestamp": "2019-06-20", "mins": 3877489}, {"id": "0000899243-19-009746", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319009746/0000899243-19-009746-index.htm", "trade_date": "2019-04-01", "timestamp": "2019-04-01", "mins": 3992689}, {"id": "0000899243-19-000518", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319000518/0000899243-19-000518-index.htm", "trade_date": "2019-01-02", "timestamp": "2019-01-02", "mins": 4120849}, {"id": "0000899243-19-000506", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924319000506/0000899243-19-000506-index.htm", "trade_date": "2019-01-01", "timestamp": "2019-01-01", "mins": 4122289}, {"id": "0000899243-18-026063", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318026063/0000899243-18-026063-index.htm", "trade_date": "2018-10-01", "timestamp": "2018-10-01", "mins": 4254769}, {"id": "0000899243-18-020661", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318020661/0000899243-18-020661-index.htm", "trade_date": "2018-07-24", "timestamp": "2018-07-24", "mins": 4354129}, {"id": "0000899243-18-017592", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 35020.0, "score": 48.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $35K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318017592/0000899243-18-017592-index.htm", "trade_date": "2018-06-20", "timestamp": "2018-06-20", "mins": 4403089}, {"id": "0000899243-18-028597", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 35020.0, "score": 48.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $35K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318028597/0000899243-18-028597-index.htm", "trade_date": "2018-06-20", "timestamp": "2018-06-20", "mins": 4403089}, {"id": "0000899243-18-015835", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 27.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders now buying TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015835/0000899243-18-015835-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-015836", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "John P. Brancaccio", "who_key": "BRANCACCIO JOHN P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 29.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015836/0000899243-18-015836-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-016465", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "John P. Brancaccio", "who_key": "BRANCACCIO JOHN P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 41.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318016465/0000899243-18-016465-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-016468", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 34.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director buys $8K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318016468/0000899243-18-016468-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-002485", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "William J. Welch", "who_key": "WELCH WILLIAM J", "role": "Chief Executive Officer, Director", "person_type": "CEO", "person_label": "CEOs", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "CEO files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318002485/0000899243-18-002485-index.htm", "trade_date": "2018-01-30", "timestamp": "2018-01-30", "mins": 4606129}, {"id": "0000899243-18-002487", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "C-suite exec files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318002487/0000899243-18-002487-index.htm", "trade_date": "2018-01-30", "timestamp": "2018-01-30", "mins": 4606129}, {"id": "0000899243-18-001898", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318001898/0000899243-18-001898-index.htm", "trade_date": "2018-01-23", "timestamp": "2018-01-23", "mins": 4616209}, {"id": "0000899243-18-001899", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Gary S. Jacob", "who_key": "JACOB GARY S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318001899/0000899243-18-001899-index.htm", "trade_date": "2018-01-23", "timestamp": "2018-01-23", "mins": 4616209}, {"id": "0000899243-18-001900", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Thomas Adams PhD", "who_key": "ADAMS THOMAS PHD", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318001900/0000899243-18-001900-index.htm", "trade_date": "2018-01-23", "timestamp": "2018-01-23", "mins": 4616209}, {"id": "0000899243-18-001901", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Athena Countouriotis", "who_key": "Countouriotis Athena", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "NON-SIGNAL", "amount": 0.0, "score": 0.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director files routine paperwork on TROV \u2014 no open-market trade", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318001901/0000899243-18-001901-index.htm", "trade_date": "2018-01-23", "timestamp": "2018-01-23", "mins": 4616209}], "recent_buys": [{"id": "0000899243-18-028597", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 35020.0, "score": 48.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $35K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318028597/0000899243-18-028597-index.htm", "trade_date": "2018-06-20", "timestamp": "2018-06-20", "mins": 4403089}, {"id": "0000899243-18-017592", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 35020.0, "score": 48.7, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The boardroom is buying: $35K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318017592/0000899243-18-017592-index.htm", "trade_date": "2018-06-20", "timestamp": "2018-06-20", "mins": 4403089}, {"id": "0000899243-18-016468", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 34.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Director buys $8K of TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318016468/0000899243-18-016468-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-016465", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "John P. Brancaccio", "who_key": "BRANCACCIO JOHN P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 41.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "3 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318016465/0000899243-18-016465-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-015836", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "John P. Brancaccio", "who_key": "BRANCACCIO JOHN P", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 29.9, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015836/0000899243-18-015836-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0000899243-18-015835", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 8000.0, "score": 27.1, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders now buying TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015835/0000899243-18-015835-index.htm", "trade_date": "2018-06-08", "timestamp": "2018-06-08", "mins": 4420369}, {"id": "0001104659-16-162837", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 21000.0, "score": 31.8, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "TROV draws its 4th insider buyer", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162837/0001104659-16-162837-index.htm", "trade_date": "2016-12-19", "timestamp": "2016-12-19", "mins": 5192209}, {"id": "0001104659-16-162787", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "William J. Welch", "who_key": "WELCH WILLIAM J", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 9943.5, "score": 51.0, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "4 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162787/0001104659-16-162787-index.htm", "trade_date": "2016-12-16", "timestamp": "2016-12-16", "mins": 5196529}, {"id": "0001104659-16-162687", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 29932.0, "score": 34.0, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "Insider cluster: 5 buying TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162687/0001104659-16-162687-index.htm", "trade_date": "2016-12-16", "timestamp": "2016-12-16", "mins": 5196529}, {"id": "0001104659-16-162330", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Mark Erlander", "who_key": "Erlander Mark", "role": "Chief Scientific Officer", "person_type": "C_SUITE", "person_label": "C-Suite", "action": "BUY", "amount": 10375.0, "score": 31.4, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "5 insiders pile into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162330/0001104659-16-162330-index.htm", "trade_date": "2016-12-14", "timestamp": "2016-12-14", "mins": 5199409}, {"id": "0001104659-15-059136", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "action": "BUY", "amount": 60599.99999999999, "score": 37.3, "price_sensitive": false, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "The whole bench is buying TROV \u2014 6 and counting", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059136/0001104659-15-059136-index.htm", "trade_date": "2015-08-12", "timestamp": "2015-08-12", "mins": 5905009}, {"id": "0001104659-15-059119", "src": "INSIDERS", "ticker": "TROV", "cik": "1213037", "company": "Cardiff Oncology, Inc.", "company_raw": "Trovagene, Inc.", "who": "Antonius Schuh", "who_key": "SCHUH ANTONIUS", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "action": "BUY", "amount": 109000.0, "score": 49.5, "price_sensitive": true, "cluster": 0, "industry": "Biological Products, (No Diagnostic Substances)", "country": "United States", "headline": "That makes 6 insiders into TROV", "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059119/0001104659-15-059119-index.htm", "trade_date": "2015-08-12", "timestamp": "2015-08-12", "mins": 5905009}], "institutional": [], "holdings": [], "directors": [], "status": {"status": "delisted", "exchange": null, "note": "No longer in the live ASX listing \u2014 delisted, acquired or merged. Historical filings are retained here; live price history ends at delisting."}, "corporate_actions": {"status_label": "", "items": []}, "key_people": [{"who": "Bridger Management, LLC", "who_key": "BRIDGER MANAGEMENT, LLC", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 6706334.12, "sold": 0, "net": 6706334.12, "trades": 4, "top_score": 55.2, "lean": "buying", "history": [{"action": "BUY", "amount": 1225000.0, "date": "2015-07-17", "score": 50.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000114036115028172/0001140361-15-028172-index.htm"}, {"action": "BUY", "amount": 2070000.0, "date": "2015-04-02", "score": 53.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000114036115014543/0001140361-15-014543-index.htm"}, {"action": "BUY", "amount": 1411336.12, "date": "2015-02-27", "score": 50.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000114036115009491/0001140361-15-009491-index.htm"}, {"action": "BUY", "amount": 1999998.0, "date": "2015-02-06", "score": 55.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000114036115005139/0001140361-15-005139-index.htm"}], "latest": {"action": "BUY", "amount": 1225000.0, "date": "2015-07-17", "score": 50.2, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000114036115028172/0001140361-15-028172-index.htm"}}, {"who": "Stanley Tennant", "who_key": "Tennant Stanley", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 298032.0, "sold": 5750.459999999999, "net": 292281.54, "trades": 8, "top_score": 42.8, "lean": "buying", "history": [{"action": "BUY", "amount": 8000.0, "date": "2018-06-08", "score": 27.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015835/0000899243-18-015835-index.htm"}, {"action": "BUY", "amount": 8000.0, "date": "2018-06-08", "score": 34.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318016468/0000899243-18-016468-index.htm"}, {"action": "SELL", "amount": 5750.459999999999, "date": "2017-09-05", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465917055831/0001104659-17-055831-index.htm"}, {"action": "BUY", "amount": 21000.0, "date": "2016-12-19", "score": 31.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162837/0001104659-16-162837-index.htm"}, {"action": "BUY", "amount": 29932.0, "date": "2016-12-16", "score": 34.0, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465916162687/0001104659-16-162687-index.htm"}, {"action": "BUY", "amount": 60599.99999999999, "date": "2015-08-12", "score": 37.3, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059136/0001104659-15-059136-index.htm"}, {"action": "BUY", "amount": 120500.0, "date": "2012-11-30", "score": 42.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912081347/0001104659-12-081347-index.htm"}, {"action": "BUY", "amount": 50000.0, "date": "2012-04-13", "score": 37.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912025723/0001104659-12-025723-index.htm"}], "latest": {"action": "BUY", "amount": 8000.0, "date": "2018-06-08", "score": 27.1, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318015835/0000899243-18-015835-index.htm"}}, {"who": "Robert Merrill Hunter", "who_key": "Hunter Robert Merrill", "role": "10% Owner", "person_type": "TEN_PCT", "person_label": "10% Owners", "bought": 200000.0, "sold": 0, "net": 200000.0, "trades": 1, "top_score": 41.4, "lean": "buying", "history": [{"action": "BUY", "amount": 200000.0, "date": "2012-04-13", "score": 41.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912025724/0001104659-12-025724-index.htm"}], "latest": {"action": "BUY", "amount": 200000.0, "date": "2012-04-13", "score": 41.4, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912025724/0001104659-12-025724-index.htm"}}, {"who": "Thomas Adams PhD", "who_key": "ADAMS THOMAS PHD", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 0, "sold": 157188.0, "net": -157188.0, "trades": 1, "top_score": 0, "lean": "selling", "history": [{"action": "SELL", "amount": 157188.0, "date": "2013-09-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465913068016/0001104659-13-068016-index.htm"}], "latest": {"action": "SELL", "amount": 157188.0, "date": "2013-09-03", "score": 0, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465913068016/0001104659-13-068016-index.htm"}}, {"who": "Gabriel Cerrone", "who_key": "CERRONE GABRIEL", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 151976.5, "sold": 0, "net": 151976.5, "trades": 4, "top_score": 39.9, "lean": "buying", "history": [{"action": "BUY", "amount": 0, "date": "2012-12-10", "score": 15.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912084986/0001104659-12-084986-index.htm"}, {"action": "BUY", "amount": 18345.0, "date": "2012-08-20", "score": 30.6, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912058850/0001104659-12-058850-index.htm"}, {"action": "BUY", "amount": 33631.5, "date": "2012-08-16", "score": 33.8, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912058599/0001104659-12-058599-index.htm"}, {"action": "BUY", "amount": 100000.0, "date": "2012-04-13", "score": 39.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912025725/0001104659-12-025725-index.htm"}], "latest": {"action": "BUY", "amount": 0, "date": "2012-12-10", "score": 15.9, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465912084986/0001104659-12-084986-index.htm"}}, {"who": "Antonius Schuh", "who_key": "SCHUH ANTONIUS", "role": "CEO, Director", "person_type": "CEO", "person_label": "CEOs", "bought": 109000.0, "sold": 0, "net": 109000.0, "trades": 1, "top_score": 49.5, "lean": "buying", "history": [{"action": "BUY", "amount": 109000.0, "date": "2015-08-12", "score": 49.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059119/0001104659-15-059119-index.htm"}], "latest": {"action": "BUY", "amount": 109000.0, "date": "2015-08-12", "score": 49.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059119/0001104659-15-059119-index.htm"}}, {"who": "Steve Zaniboni", "who_key": "ZANIBONI STEVE", "role": "CFO", "person_type": "C_SUITE", "person_label": "C-Suite", "bought": 106449.55, "sold": 0, "net": 106449.55, "trades": 2, "top_score": 60.5, "lean": "buying", "history": [{"action": "BUY", "amount": 81450.0, "date": "2015-08-12", "score": 60.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059036/0001104659-15-059036-index.htm"}, {"action": "BUY", "amount": 24999.550000000003, "date": "2014-06-09", "score": 39.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465914045104/0001104659-14-045104-index.htm"}], "latest": {"action": "BUY", "amount": 81450.0, "date": "2015-08-12", "score": 60.5, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000110465915059036/0001104659-15-059036-index.htm"}}, {"who": "Rodney S. Markin", "who_key": "Markin Rodney S", "role": "Director", "person_type": "BOARD", "person_label": "Board", "bought": 70040.0, "sold": 0, "net": 70040.0, "trades": 2, "top_score": 48.7, "lean": "buying", "history": [{"action": "BUY", "amount": 35020.0, "date": "2018-06-20", "score": 48.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318017592/0000899243-18-017592-index.htm"}, {"action": "BUY", "amount": 35020.0, "date": "2018-06-20", "score": 48.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318028597/0000899243-18-028597-index.htm"}], "latest": {"action": "BUY", "amount": 35020.0, "date": "2018-06-20", "score": 48.7, "source_url": "https://www.sec.gov/Archives/edgar/data/1213037/000089924318017592/0000899243-18-017592-index.htm"}}], "activity": [], "announcements": [{"form": "3", "date": "2026-10-27", "title": "Initial insider holdings", "accession": "0001493152-26-048722", "price_sensitive": false}, {"form": "8-K", "date": "2026-10-27", "title": "Material event", "accession": "0001493152-26-048720", "price_sensitive": true}, {"form": "8-K", "date": "2026-10-22", "title": "Material event", "accession": "0001493152-26-048111", "price_sensitive": true}, {"form": "8-K", "date": "2026-09-14", "title": "Material event", "accession": "0001493152-26-042506", "price_sensitive": true}, {"form": "DEFA14A", "date": "2026-08-26", "title": "Form DEFA14A", "accession": "0001193125-26-368287", "price_sensitive": false}, {"form": "DEF 14A", "date": "2026-08-26", "title": "Proxy statement", "accession": "0001193125-26-368249", "price_sensitive": false}, {"form": "PRE 14A", "date": "2026-08-14", "title": "Form PRE 14A", "accession": "0001193125-26-352135", "price_sensitive": false}, {"form": "8-K", "date": "2026-08-11", "title": "Material event", "accession": "0001193125-26-344645", "price_sensitive": true}, {"form": "10-Q", "date": "2026-08-11", "title": "Quarterly report", "accession": "0001193125-26-344545", "price_sensitive": true}, {"form": "SCHEDULE 13G/A", "date": "2026-07-27", "title": "Form SCHEDULE 13G/A", "accession": "0002012383-26-002222", "price_sensitive": false}, {"form": "S-8", "date": "2026-07-21", "title": "Employee share plan", "accession": "0001193125-26-310273", "price_sensitive": false}, {"form": "4", "date": "2026-07-16", "title": "Insider transaction", "accession": "0001193125-26-306083", "price_sensitive": false}, {"form": "4", "date": "2026-07-16", "title": "Insider transaction", "accession": "0001193125-26-306072", "price_sensitive": false}, {"form": "8-K", "date": "2026-07-16", "title": "Material event", "accession": "0001193125-26-305467", "price_sensitive": true}, {"form": "424B5", "date": "2026-07-16", "title": "Prospectus", "accession": "0001193125-26-305465", "price_sensitive": false}, {"form": "4", "date": "2026-06-22", "title": "Insider transaction", "accession": "0001664708-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-22", "title": "Insider transaction", "accession": "0001184778-26-000009", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001370087-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001635493-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001543174-26-000005", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001393415-26-000002", "price_sensitive": false}, {"form": "4", "date": "2026-06-15", "title": "Insider transaction", "accession": "0001184778-26-000007", "price_sensitive": false}, {"form": "8-K", "date": "2026-06-11", "title": "Material event", "accession": "0001193125-26-267563", "price_sensitive": true}, {"form": "8-K", "date": "2026-06-03", "title": "Material event", "accession": "0001193125-26-254658", "price_sensitive": true}, {"form": "8-K", "date": "2026-05-29", "title": "Material event", "accession": "0001193125-26-248711", "price_sensitive": true}], "performance": {"ticker": "TROV", "has_prices": false, "summary": null, "buys": [{"who": "Markin Rodney S", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 35020.0, "date": "2018-06-20", "score": 48.7, "ref_price": null, "return": null}, {"who": "Markin Rodney S", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 35020.0, "date": "2018-06-20", "score": 48.7, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8000.0, "date": "2018-06-08", "score": 34.4, "ref_price": null, "return": null}, {"who": "BRANCACCIO JOHN P", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8000.0, "date": "2018-06-08", "score": 41.5, "ref_price": null, "return": null}, {"who": "BRANCACCIO JOHN P", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8000.0, "date": "2018-06-08", "score": 29.9, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 8000.0, "date": "2018-06-08", "score": 27.1, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 21000.0, "date": "2016-12-19", "score": 31.8, "ref_price": null, "return": null}, {"who": "WELCH WILLIAM J", "person_type": "CEO", "person_label": "CEOs", "role": "CEO, Director", "amount": 9943.5, "date": "2016-12-16", "score": 51.0, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 29932.0, "date": "2016-12-16", "score": 34.0, "ref_price": null, "return": null}, {"who": "Erlander Mark", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "Chief Scientific Officer", "amount": 10375.0, "date": "2016-12-14", "score": 31.4, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 60599.99999999999, "date": "2015-08-12", "score": 37.3, "ref_price": null, "return": null}, {"who": "SCHUH ANTONIUS", "person_type": "CEO", "person_label": "CEOs", "role": "CEO, Director", "amount": 109000.0, "date": "2015-08-12", "score": 49.5, "ref_price": null, "return": null}, {"who": "ZANIBONI STEVE", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CFO", "amount": 81450.0, "date": "2015-08-12", "score": 60.5, "ref_price": null, "return": null}, {"who": "BRIDGER MANAGEMENT, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1225000.0, "date": "2015-07-17", "score": 50.2, "ref_price": null, "return": null}, {"who": "BRIDGER MANAGEMENT, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 2070000.0, "date": "2015-04-02", "score": 53.9, "ref_price": null, "return": null}, {"who": "BRIDGER MANAGEMENT, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1411336.12, "date": "2015-02-27", "score": 50.9, "ref_price": null, "return": null}, {"who": "BRIDGER MANAGEMENT, LLC", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 1999998.0, "date": "2015-02-06", "score": 55.2, "ref_price": null, "return": null}, {"who": "ZANIBONI STEVE", "person_type": "C_SUITE", "person_label": "C-Suite", "role": "CFO", "amount": 24999.550000000003, "date": "2014-06-09", "score": 39.5, "ref_price": null, "return": null}, {"who": "CERRONE GABRIEL", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 0.0, "date": "2012-12-10", "score": 15.9, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 120500.0, "date": "2012-11-30", "score": 42.8, "ref_price": null, "return": null}, {"who": "CERRONE GABRIEL", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 18345.0, "date": "2012-08-20", "score": 30.6, "ref_price": null, "return": null}, {"who": "CERRONE GABRIEL", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 33631.5, "date": "2012-08-16", "score": 33.8, "ref_price": null, "return": null}, {"who": "CERRONE GABRIEL", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 100000.0, "date": "2012-04-13", "score": 39.9, "ref_price": null, "return": null}, {"who": "Hunter Robert Merrill", "person_type": "TEN_PCT", "person_label": "10% Owners", "role": "10% Owner", "amount": 200000.0, "date": "2012-04-13", "score": 41.4, "ref_price": null, "return": null}, {"who": "Tennant Stanley", "person_type": "BOARD", "person_label": "Board", "role": "Director", "amount": 50000.0, "date": "2012-04-13", "score": 37.6, "ref_price": null, "return": null}]}, "price_series": [], "refreshing": true}